| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035047 |
| Receipt No. | R000039958 |
| Scientific Title | Clinical investigation of ninjin'yoeito for psychiatric symptoms and physical frailty among patients with mild cognitive impairment and Alzheimer's disease. |
| Date of disclosure of the study information | 2018/11/28 |
| Last modified on | 2019/12/23 (Ver. 6) |
| Basic information | ||
| Public title | Clinical investigation of ninjin'yoeito for psychiatric symptoms and physical frailty among patients with mild cognitive impairment and Alzheimer's disease. | |
| Acronym | Effect of ninjin'yoeito among patients with mild cognitive impairment and Alzheimer's disease. | |
| Scientific Title | Clinical investigation of ninjin'yoeito for psychiatric symptoms and physical frailty among patients with mild cognitive impairment and Alzheimer's disease. | |
| Scientific Title:Acronym | Effect of ninjin'yoeito among patients with mild cognitive impairment and Alzheimer's disease. | |
| Region |
|
|
| Condition | ||
| Condition | mild cognitive impairment or Alzheimer's disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We investigate the efficacy of ninjinyoeito on psychiatric symptoms and physical frailty in patients with mild cognitive impairment and early to moderate Alzheiemr's disease. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Psychiatric symptoms: the Neuropsychiatric Inventory at 12 weeks |
| Key secondary outcomes | 12 weeks
1) Weight (Body mass index) 2) Nutritional status: Mini Nutritional Assessment-short form 3) Appetite: Simplified Nutritional Appetite Questionnaire 4) Physical performance: grip strength, timed Up and Go test 5) Body composition: Bioelectrical impedance analysis 6) Physical activities: International Physical Activity Questionnaire short version 7) Cognitive function: Mini Mental State Examination 8) Vitality: Vitality Index 9) Depressive mood: 15-Geriatric depression scale |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Kracie Ninjinyoeito Extract Granules, 7.5g per day, 12 weeks | |
| Interventions/Control_2 | No treatment | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients who suffer from weakness, exhaustion, and/or anorexia.
2) Patients with apathy. 3) Patients who were diagnosed with mild cognitive impairment or early to moderate Alzheimer's disease based on the criteria of the NIA-AA. 4) Patients who have MMSE score of 11 points or more. 5) Patients who can walk without assistance. 6) Patients who have provided consent for participation by each subject and a family or caregiver. 7) Patients who can receive cooperation from family or caregiver. |
|||
| Key exclusion criteria | 1) Patients who have been taken other kampo medicines in the past month.
2) Patients who have MMSE score of 10 points or less. 3) Patients who switched or newly started using anti-dementia medications within 3 months from the start of the survey. 4) Patients who have been taking sweetroot-containing drug and/or glycyrrhizinate-containing drug. 5) Patients who switched or newly started using antipsychotic medications within 3 months from the start of the survey. 6) Patients who have mental disorders caused by cerebrovascular disorders, head injuries, brain tumors, or encephalitis. 7) Patients whom investigators consider to be ineligible. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center Geriatrics and Gerontology | ||||||
| Division name | Center for Comprehensive Care and Research on Memory Disorders | ||||||
| Zip code | 474-8511 | ||||||
| Address | 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan | ||||||
| TEL | 0562-46-2311 | ||||||
| tsakurai@ncgg.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center Geriatrics and Gerontology | ||||||
| Division name | Center for Comprehensive Care and Research on Memory Disorders | ||||||
| Zip code | 474-8511 | ||||||
| Address | 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan | ||||||
| TEL | 0562-46-2311 | ||||||
| Homepage URL | |||||||
| tsakurai@ncgg.go.jp | |||||||
| Sponsor | |
| Institute | National Center Geriatrics and Gerontology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kracie & CO. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Research and Medical Division |
| Address | 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan |
| Tel | 0562-46-2311 |
| yaday@ncgg.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 10 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039958 |